HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $447,590 | -1.4% | 11,717 | -6.9% | 0.02% | +4.2% |
Q2 2023 | $453,797 | +7.0% | 12,581 | +13.2% | 0.02% | -4.0% |
Q1 2023 | $424,291 | -34.9% | 11,110 | -2.9% | 0.02% | -40.5% |
Q4 2022 | $651,334 | +34.0% | 11,447 | -6.8% | 0.04% | +23.5% |
Q3 2022 | $486,000 | -19.8% | 12,284 | -10.8% | 0.03% | -17.1% |
Q2 2022 | $606,000 | +9.0% | 13,775 | -1.2% | 0.04% | +28.1% |
Q1 2022 | $556,000 | -0.7% | 13,949 | +0.1% | 0.03% | +3.2% |
Q4 2021 | $560,000 | -1.6% | 13,931 | -0.4% | 0.03% | -11.4% |
Q3 2021 | $569,000 | -10.8% | 13,988 | -0.5% | 0.04% | -10.3% |
Q2 2021 | $638,000 | -7.1% | 14,052 | -12.7% | 0.04% | -17.0% |
Q4 2020 | $687,000 | – | 16,095 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |